Key Event Details
A routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the Sterile Product Division (SPD) facility of OneSource Specialty Pharma Limited.
Facility and Inspection Period
The inspection took place at the facility located at Opp. IIM, Bilekahalli, Bannerghatta Road, Bengaluru, 560076. The inspection period was from June 22, 2026, to June 30, 2026.
Inspection Outcome
The inspection concluded with one observation. The nature or details of the observation were not disclosed.
Company's Response and Forward Plan
The Company will respond to the observation comprehensively and will submit this response to the FDA within the stipulated time frame.
Undertaking to Exchanges
The company has undertaken to keep the stock exchanges informed of any further developments in this matter.